Genmab — Juli 2019
-
Det ser da så skidt ud....lukkekurs 8. juli 2016...1202.
-
I februar 2016 var vi i 638.

-
I oktober 2018 var vi i 796. Lidt styrke er der trods alt i aktien.

-
Den ene får behandling her: https://www.royalmarsden.nhs.uk/rm-magazine/our-blood
-
-
-
@sukkeralf - tak, interessant indeed. Og bemærkelsesværdigt at Iovance har en market cap på $ 3mia med nul omsætning og en håndfuld lægemiddelkandidater der addresserer de samme områder som Genmab, men ikke er i nærheden af at være godkendte eller på markedet.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind